Camp Okizu, a Refuge for Families Affected by Childhood Cancer, Pledges to Rise from the Ashes
The camp was co-founded by Arthur Ablin, MD, the former chief of pediatric oncology at UCSF.
University of California San Francisco
Give to UCSF
Displaying 181 - 210 of 1062
-
-
‘Invisible’ Stem Cells Evade Natural Killer Cells Using Immune ‘Off-Switch’
UCSF scientists have discovered a new way to control the immune system’s “natural killer” cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection.
-
Cancer Metastasis is Target of New Research Initiative
A new research collaborative at UCSF will be focused on decoding the “rulebook” of metastatic cancer as a pathway to new treatments.
-
Novel Tool Deciphers Cells’ Energetic Code to Enhance Anticancer Therapies
Immunotherapies are a promising anticancer arsenal and work by mobilizing the immune system to recognize and destroy cancer cells. Currently, however, only a third of patients respond to
-
UCSF, UCLA Gain FDA Approval for Prostate Cancer Imaging Technique
The imaging technique for prostate cancer locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.
-
Big Data Powers Design of ‘Smart’ Cell Therapies for Cancer
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research.
-
Breast Cancer Study Hits 30K Milestone in Demystifying Risk
A new, $9 million grant from the National Cancer Institute to increase ethnic diversity will help the study work toward a goal of enrolling 100,000 or more women overall.
-
Climate Change Will Give Rise to More Cancers
Climate change will bring an acute toll worldwide, with rising temperatures, wildfires and poor air quality, accompanied by higher rates of cancer, especially lung, skin and gastrointestinal cancers.
-
Axing the ACA Means Young Adults with Cancer Lose Coverage
Researchers found that patients with a pediatric cancer who were protected under the ACA’s dependent coverage provision were more likely to remain on private insurance for longer durations compared to their older peers who turned 19 before the Act.
-
Risk of Deadly Skin Cancer May Be Gauged by Accumulated DNA Damage
Risk for melanoma, the most deadly skin cancer, can be estimated long before detection of any suspicious moles, according to a UCSF scientist.
-
3 UCSF Researchers Win NIH New Innovator Awards
The UCSF researchers — whose work spans investigations into autism spectrum disorder (ASD), oncology, and mitochondrial disease — were among 85 awardees for the grants that the NIH says “will fund highly innovative and unusually impactful biomedical or behavioral research proposed by extraordinarily creative scientists.”
-
Cancer Immunotherapy ‘Uniquely Suppressed’ by Liver Tumors
Though cancer immunotherapy has become a promising standard-of-care treatment – and in some cases, perhaps a cure – for a wide variety of different cancers, it doesn’t work for everyone, and researchers have increasingly turned their attention to understanding why.
-
Health Care Inequality Could Deepen With Precision Oncology
-
Mapping Genetic Diversity of Lung Tumors Over Time May Lead to More Effective Therapies
Researchers have figured out how to assemble genetic profiles of individual lung cancer cells obtained from patients at different times during the course of their treatment.
-
UCSF Doctor Hopes Death of Actor Chadwick Boseman Will Raise Awareness as More Young People Diagnosed With Colon Cancer
-
UCSF Medical Center Ranks Among Nation’s 10 Best Hospitals for 2020-21
UCSF Medical Center has been recognized as one of the nation’s finest hospitals in the U.S. News & World Report 2020-2021 Best Hospitals survey, ranking among the top 10 hospitals nationwide for the 22nd year.
-
Sheltering in Place Is Nothing New for These Families
When your child has a serious medical condition, social distancing is all too familiar. Five families have some advice for the rest of us.
-
Largest-Ever Study of Prostate Cancer Genomics in Black Men IDs Potential Targets for Precision Therapies
None of the individual tumor genetic differences that were identified are likely to explain significant differences in health outcomes or to prevent Black Americans from benefiting from a new generation of precision prostate cancer therapies, researchers say, as long as the therapies are applied equitably.
-
New Model of Breast Cancer’s Causes Developed by UCSF-led Team
A new model of the causes of breast cancer, created by a team led by researchers at UCSF, Genentech and Stanford University, is designed to capture the complex interrelationships between dozens of primary and secondary breast cancer causes and stimulate further research.
-
‘Scientifically Fearless’ Cancer Researcher Zena Werb Dies at 75
Colleagues are mourning the passing of Zena Werb, PhD, a giant in the field of cancer biology whose four decades of research at UCSF informed the rise of immunotherapy and other modern approaches to cancer treatment.
-
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies
Under a new agreement, Celgene will further invest in the RAN’s state-of-the-art antibody engineering program to expand target discovery from oncology and immunology to include neurology.
-
UCSF, St. Jude Identify Key Culprit Driving Treatment Resistance in Deadly Immune Disorder
The finding could offer additional insights into other immune conditions, including a type of childhood leukemia and the severe inflammation response in some children with COVID-19.
-
UCSF Benioff Children’s Hospitals Rank Among the Nation’s Best for 10 Specialties in 2020-2021 U.S. News & World Report
The annual U.S. News rankings serve as a guide of hospitals nationwide that excel in treating children with the most challenging diagnoses.
-
Tumors Disrupt the Immune System Throughout the Body
Depending on a cancer’s tissue of origin, tumors cause widespread and variable disruption of the immune system throughout the body, not just at the primary tumor site.
-
UCSF Cancer Researchers Present New Advances at ASCO 2020
Cancer specialists from UCSF will present new research findings at the annual scientific program of the American Society of Clinical Oncology, the world’s largest clinical cancer research meeting.
-
2 UCSF Faculty to Lead New Research Institutes
Two UCSF faculty will lead the new institutes.
-
Flipping A Genetic Switch on Cells Lets Researchers Boost or Suppress Immune Responses
Cancer and autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, might not seem to have much in common, but some researchers now are pinning hopes on the same immune system cell –
-
CRISPR-Based ‘Discovery Engine’ for New Cell Therapies to Advance Cancer Treatments
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.
-
More Aggressive Surgery Can Extend Survival From Brain Cancer: Study
-
New Cancer Care Center Opened This Week